APG2575

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLLNCT05147467Ascentage Pharma Group Inc.Phase 2Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.